-
GRPR Antagonists Beyond PSMA in Prostate Cancer Detection and Treatment "Presentation" - Andrei Iagaru
24 Apr 2025 03:36 GMT
… of cancer types, including prostate cancer, but also are involved … well as antagonists. The bone scan was there for them, … scenario that 90% of prostate cancer overexpress PSMA, not 100% … , it also has less prostate cancer lesions activity. So perhaps it …
-
PSMA-Targeted Antibodies for Prostate Cancer Radioligand Therapy "Presentation" - Scott Tagawa
18 Apr 2025 01:48 GMT
Read the Full Video Transcript
Scott Tagawa: All right. Thanks for the invitation. I'm going to shift gears a little bit. Still PSMA, but I'm going to talk about antibodies. I'm going to take a minute to tell you—I don't have an outline, so …
-
Telix's Illuccix prostate cancer PSMA─PET imaging agent approved in the Netherlands
19 Mar 2025 07:12 GMT
… company, announces that its prostate cancer PET imaging agent Illuccix … positive progressive metastatic castration-resistant prostate cancer (mCRPC) for whom … in prostate cancer management, largely replacing conventional imaging methods (bone scan, CT …
-
‘Groundbreaking’ scan for men with prostate cancer could save lives
11 Mar 2025 11:23 GMT
… . Men diagnosed with aggressive prostate cancer currently undergo two types of … for prostate cancer spread in men, using a CT and a bone scan, can … Hobbs, director of research at Prostate Cancer UK, which is funding … for men with high-risk prostate cancers.”
-
New scanning technology trialled for prostate cancer patients
11 Mar 2025 09:26 GMT
… prostate cancer spread in men, using a CT and a bone scan, … at Prostate Cancer UK, said: “Knowing that your prostate cancer is … men with high-risk prostate cancers.
Prostate cancer is a complex, but … more precise treatment.
Prostate Cancer UK is supporting the …
-
Prostate cancer series: diagnostics 2
04 Mar 2025 17:33 GMT
… team meeting. His prostate cancer was confirmed to fulfil … risk stratification categories for prostate cancer?
Being high risk, … 82%, respectively. For bone scan, the sensitivity and specificity … metastases in patients with prostate cancer: a meta-analysis. …
-
ARASTEP Trial Tests Darolutamide and ADT in High-Risk Biochemically Recurrent Prostate Cancer - Alicia Morgans
26 Feb 2025 03:34 GMT
… high-risk biochemical recurrence of prostate cancer identified by PSMA PET.
So … in the metastatic hormone-sensitive prostate cancer population. And it's … , so no metastases on conventional bone scan, CTs, MRIs. They have to …
-
Receiving NADT for 6 Months Doesn’t Impact Outcomes in Intermediate-Risk Prostate Cancer After EBRT
14 Feb 2025 17:39 GMT
… patients with intermediate-risk prostate cancer did not improve prostate cancer–specific survival or … improves survival of intermediate-risk prostate cancer. Are there any characteristics of … the majority of my career—bone scan or CTs didn't …
-
UK MHRA grants marketing authorization to Telix’s prostate cancer PET imaging agent, Illuccix
14 Feb 2025 04:31 GMT
… Application (MAA) for its prostate cancer PET imaging agent Illuccix (kit … advancement in prostate cancer management, largely replacing conventional imaging methods (bone scan, CT … the most important developments in prostate cancer detection in recent years …
-
Prostate Cancer Bone Metastasis: Molecular Mechanisms of Tumor and Bone Microenvironment
01 Feb 2025 10:18 GMT
… prostate tumors in the bone microenvironment. Mesenchymal stem cells induce already disseminated prostate cancer … facilitating metastatic prostate tumor growth in … cells into prostate tumours promotes metastasis … in Prostate Cancer using Bone Scan Index …